Comparison of Autologous Chondrocyte Implantation Versus Mosaicoplasty: a Randomized Trial (Cartipatch)
Phase 3 Study Comparison of Autologous Chondrocyte Implantation Versus Mosaicoplasty
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
This PHASE3 trial investigates Knee Chondral or Osteochondral Defect and is currently completed. Institut National de la Santé Et de la Recherche Médicale, France leads this study, which shows 7 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Jan 2026 — Present [monthly]
Completed PHASE3
-
Sep 2025 — Jan 2026 [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Apr 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Institut National de la Santé Et de la Recherche Médicale, France
- University Hospital, Brest
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Brest, France , Caen, France , Dracy-le-Fort, France , Grenoble, France , Le Chesnay, France , Limoges, France , Lyon, France , Mayenne, France , Nancy, France , Saint-Mandé, France and 2 more locations